Mercy Hospital St. Louis-South is a clinical research site located in St Louis, Missouri, United States 63128.
Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.
Mercy Hospital St. Louis-South has participated in 1 clinical trials.
Therapeutic areas: PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Metastatic Pancreas Adenocarcinoma.
Sponsors: Revolution Medicines, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Missouri · View every site in St Louis
Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mercy Hospital St. Louis-South has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mercy Hospital St. Louis-South has 1 clinical trials on record. Their work covers PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Metastatic Pancreas Adenocarcinoma.
Mercy Hospital St. Louis-South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.